New Zealand Consumer Finance Stock News

Meridian Energy Limited recently announced a new share repurchase program of up to 500,000 shares to be held in treasury for its FY26 long-term incentive scheme, alongside news that independent director Michelle Henderson will resign in January 2026 following her appointment as General Manager of New Zealand Aluminium Smelters. This combination of capital management via a targeted buyback and a board change linked to a key industrial customer relationship could influence how investors assess...

Seeka Limited ( NZSE:SEK ) stock is about to trade ex-dividend in four days. The ex-dividend date is two business days...

We wouldn't blame Gentrack Group Limited ( NZSE:GTK ) shareholders if they were a little worried about the fact that...

Fletcher Building (NZSE:FBU) just took a big step in its clean up job on the balance sheet by exiting its US private placement debt, adding fresh bank lines, and extending key covenants to keep liquidity comfortable. See our latest analysis for Fletcher Building. Those balance sheet moves seem to be resonating with investors, with a roughly 20 percent 3 month share price return and a 1 year total shareholder return near 28 percent, which suggests momentum is rebuilding after a tough few...

To the annoyance of some shareholders, EROAD Limited ( NZSE:ERD ) shares are down a considerable 34% in the last month...

As global markets enter December 2025, investor optimism is buoyed by hopes of an interest rate cut from the Federal Reserve, with major U.S. stock indexes, particularly the technology-heavy Nasdaq Composite and small-cap Russell 2000 Index, posting gains. Amid this backdrop of cautious economic indicators such as a contracting manufacturing sector and fluctuating employment figures, high-growth tech stocks remain a focal point for investors seeking opportunities in sectors poised to benefit...

As global markets closely watch the Federal Reserve's upcoming meeting with hopes of an interest rate cut, Asian economies are navigating a complex landscape marked by mixed manufacturing and services activity. In this environment, dividend stocks in Asia can offer investors a potential source of steady income, especially when inflationary pressures and economic uncertainties persist.

The board of Scales Corporation Limited ( NZSE:SCL ) has announced that it will be paying its dividend of NZ$0.15 on...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Anyone interested in EROAD Limited ( NZSE:ERD ) should probably be aware that a company insider, David Kenneson...

When close to half the companies in New Zealand have price-to-earnings ratios (or "P/E's") below 18x, you may consider...

Ryman Healthcare (NZSE:RYM) just released half-year numbers that will make investors sit up. Revenue is climbing, but the company has shifted from a solid profit to a net loss. See our latest analysis for Ryman Healthcare. The NZ$2.88 share price reflects a mixed story, with a solid 90 day share price return of 15.66% but a steep year to date share price decline and weak multi year total shareholder returns. This hints that sentiment is only cautiously improving after the earnings setback. If...

Port of Tauranga Limited recently announced that the Minister for Infrastructure has accepted its request to refer the Stella Passage development resource consent application to the fast-track consenting process, running in parallel with the existing but paused application affected by a judicial review and legislative uncertainty. This alternative fast-track route is important because it aims to keep the Stella Passage project moving despite a legislative drafting error that has stalled the...

Key Insights Institutions' substantial holdings in Contact Energy implies that they have significant influence over the...

In recent months, Air New Zealand has reported slightly higher passenger volumes with a marginally lower load factor, while also facing pockets of operational disruption across domestic and trans-Tasman routes. At the same time, the airline has drawn attention with world-first SYNTHONY inflight concerts and early-stage electric and hydrogen aircraft trials, underscoring a dual push into differentiated customer experiences and lower-emission aviation. We’ll now examine how Air New Zealand’s...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Global markets have been experiencing a mix of optimism and caution, with major U.S. stock indexes advancing amid hopes for an interest rate cut from the Federal Reserve. As investors navigate these changing conditions, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities despite their somewhat outdated designation. With strong financial health, these stocks can defy expectations and present growth potential at lower price points, making them...

EBOS Group Limited's ( NZSE:EBO ) price-to-earnings (or "P/E") ratio of 23x might make it look like a sell right now...

Green Cross Health Limited ( NZSE:GXH ) recently posted some strong earnings, and the market responded positively. We...

Key Insights Fonterra Co-operative Group will host its Annual General Meeting on 11th of December CEO Miles Hurrell's...

With a median price-to-earnings (or "P/E") ratio of close to 18x in New Zealand, you could be forgiven for feeling...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But in contrast you can...

Genesis Energy has reached Final Investment Decision for the 136 MWp Edgecumbe Solar Farm in New Zealand’s Bay of Plenty, targeting first generation in the second half of FY27 under its Gen35 renewable strategy. The on-balance-sheet funding of Edgecumbe, with potential capital recycling post-commissioning, highlights Genesis’s flexible approach to financing growth while aiming to preserve its BBB+ credit rating. Next, we’ll examine how committing to the 136 MWp Edgecumbe Solar Farm could...

Fisher & Paykel Healthcare has already reported half-year 2025 results showing sales of NZ$1,088.5 million and net income of NZ$213.0 million, alongside higher basic earnings per share and an increased interim dividend. The company also raised its full-year revenue and net profit guidance, signaling management confidence that recent operational momentum can continue. Next, we’ll explore how the upgraded full-year earnings guidance may influence Fisher & Paykel Healthcare’s existing...